The 32nd Congress of ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) will be held September 14-17 of this year in London, UK. Among the many topics there will be a debate on this subject:
Arguing "Yes" will be K. Schmierer (London, UK), and arguing "No" will be P. K. Coyle (Stony Brook, NY, USA).People in wheelchairs should be included in MS clinical trials
This burning debate will address the topical issue of whether people in wheelchairs should be included in trials for progressive MS. Two opposing views will be put forward to spark debate about the reasons why a significant portion of people with MS are excluded from clinical trials of disease-modifying [treatments].
Do the experts feel that a clinical trial would be too risky for someone whose MS is advanced enough to require a wheelchair?
Maybe more answers about this will be forthcoming in September. There may be an available abstract of the discussion.